financetom
Business
financetom
/
Business
/
United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing
Apr 9, 2024 1:53 PM

04:40 PM EDT, 04/09/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on April 05, 2024, sold 20,060 shares in United Therapeutics ( UTHR ) for $4,727,736. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 130 shares of the company, with 130 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000141588924010571/xslF345X03/form4-04092024_040402.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nu Holdings Q1 Earnings, Revenue Increase -- Shares Decline
Nu Holdings Q1 Earnings, Revenue Increase -- Shares Decline
May 14, 2024
04:38 PM EDT, 05/14/2024 (MT Newswires) -- Nu Holdings ( NU ) reported Q1 earnings Tuesday of $0.08 per diluted share, up from $0.03 a year earlier. Analysts polled by Capital IQ expected $0.07. Revenue for the quarter ended March 31 was $2.74 billion, up from $1.62 billion a year earlier. Analysts surveyed by Capital IQ expected $2.53 billion. Shares...
Infinera Swings to Preliminary Q1 Non-GAAP Loss, Revenue Falls; Issues Q2 Outlook -- Shares Fall After Hours
Infinera Swings to Preliminary Q1 Non-GAAP Loss, Revenue Falls; Issues Q2 Outlook -- Shares Fall After Hours
May 14, 2024
04:38 PM EDT, 05/14/2024 (MT Newswires) -- Infinera ( INFN ) reported a Q1 preliminary non-GAAP loss late Tuesday of $0.17 per diluted share, compared with earnings of $0.02 per share a year earlier. Analysts polled by Capital IQ expected a loss of $0.13. Preliminary revenue for the quarter ended March 30 was $306.9 million, down from $392.1 million a...
United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing
May 14, 2024
04:39 PM EDT, 05/14/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 10, 2024, sold 7,200 shares in United Therapeutics ( UTHR ) for $1,911,532. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 130 shares of the company, with 130 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000141588924013129/xslF345X03/form4-05142024_040509.xml ...
Targa Resources Insider Sold Shares Worth $2,262,690, According to a Recent SEC Filing
Targa Resources Insider Sold Shares Worth $2,262,690, According to a Recent SEC Filing
May 14, 2024
04:37 PM EDT, 05/14/2024 (MT Newswires) -- D. Scott Pryor, President, Logistics and Transportation, on May 13, 2024, sold 20,000 shares in Targa Resources ( TRGP ) for $2,262,690. Following the Form 4 filing with the SEC, Pryor has control over a total of 177,928 shares of the company, with 41,830 shares held directly and 136,098 controlled indirectly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved